| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 30.880 | 21.368 | 0 | 88.798 | 129.363 | 145.709 | 148.645 | 153.516 |
| Total Income - EUR | - | - | 30.880 | 21.368 | 0 | 88.798 | 129.363 | 145.709 | 148.684 | 154.288 |
| Total Expenses - EUR | - | - | 1.263 | 6.496 | 2.037 | 3.155 | 14.860 | 35.655 | 58.928 | 69.584 |
| Gross Profit/Loss - EUR | - | - | 29.618 | 14.872 | -2.037 | 85.643 | 114.502 | 110.054 | 89.756 | 84.704 |
| Net Profit/Loss - EUR | - | - | 29.031 | 14.520 | -2.037 | 83.659 | 111.395 | 107.222 | 88.706 | 80.168 |
| Employees | - | - | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Bugarimedical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 9.193 | 32.589 | 94.409 | 72.574 | 50.864 |
| Current Assets | - | - | 29.634 | 43.224 | 40.350 | 117.821 | 86.350 | 106.076 | 72.658 | 83.087 |
| Inventories | - | - | 0 | 0 | 0 | 827 | 1.192 | 3.320 | 1.192 | 1.185 |
| Receivables | - | - | 4.337 | 5.664 | 5.555 | 5.466 | 5.345 | 97.509 | 21.362 | 67.882 |
| Cash | - | - | 25.297 | 37.560 | 34.795 | 111.528 | 79.813 | 5.246 | 50.105 | 14.020 |
| Shareholders Funds | - | - | 29.074 | 43.061 | 40.190 | 123.088 | 111.443 | 107.271 | 106.493 | 80.217 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 560 | 163 | 160 | 3.927 | 7.496 | 93.214 | 38.740 | 53.735 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Bugarimedical Srl